Reprogramming of somatic cells
The disclosure relates to a method of reprogramming one or more somatic cells, e.g., partially differentiated or fully/terminally differentiated somatic cells, to a less differentiated state, e.g., a pluripotent or multipotent state. In further embodiments the invention also relates to reprogrammed somatic cells produced by methods of the invention, to uses of said cells, and to methods for identifying agents useful for reprogramming somatic cells.
1. A purified preparation of isolated pluripotent mammalian cells, wherein the cells
(a) express endogenous Oct4 and Nanog;
(b) differentiate into tissues having the characteristics of endoderm, mesoderm, and ectoderm when injected into SCID mice;
(c) do not express a nucleic acid encoding a selectable marker operably linked to an endogenous pluripotency gene; and
(d) are reprogrammed mammalian somatic cells that comprise exogenously introduced polynucleotides encoding Oct4, Sox2, and Klf4, but not c-Myc.
2. The purified preparation of cells of claim 1 , wherein at least about 50% of the cells are resistant to DNA methylation.
3. The purified preparation of cells of claim 1 , wherein the cells survive and DNA methyltransferase I expression in the cells is reduced by at least 50%.
4. The purified preparation of cells of claim 1 , wherein the genome of said cells is not genetically modified.
5. The purified preparation of cells of claim 1 , wherein said cells comprise at least one genetic modification of the genome of said cells.
6. The purified preparation of cells of claim 1 , wherein the cells are genetically matched to a donor of said somatic cells or a donor of a precursor cell of said somatic cells, wherein said donor is an individual in need of cell therapy.
7. The purified preparation of cells of claim 1 , wherein the cells do not express an exogenously introduced pluripotency gene.